Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory securities class action

Park Ha Biological Securities Class Action

Analysis based on 89 articles · First reported Jul 28, 2026 · Last updated Aug 23, 2026

Sentiment
-60
Attention
4
Articles
89
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The securities class actions against Park Ha Biological Technology Company highlight alleged market manipulation and fraudulent promotion, which could lead to significant financial penalties and reputational damage for the company. The collapse of the stock price and the ensuing litigation may deter investors from similar small-cap IPOs and increase scrutiny on promotional practices in the biotech sector.

Biotechnology Securities Litigation

Multiple law firms, including Bronstein, Gewirtz & Grossman, Pomerantz, Rosen Law Firm, Levi & Korsinsky (SueWallSt), The Gross Law Firm, and Robbins LLP, have filed or announced securities class actions against Park Ha Biological Technology Company Co., Ltd. (NASDAQ: BYAH, PHH) and certain officers. The lawsuits allege that Park Ha made false and misleading statements during the Class Period from December 27, 2024 to July 8, 2025, failing to disclose a fraudulent stock promotion and market manipulation scheme. According to the complaints, Park Ha's IPO was structured with an extremely low public float, and social media misinformation and impersonated financial professionals artificially inflated the stock price from $4.00 IPO price to an intraday high of $41.49 on July 7, 2025. The stock collapsed approximately 93% on July 8, 2025, closing at $2.99, erasing nearly $1 billion in market capitalization. The lawsuits seek damages for investors who purchased Park Ha securities during the Class Period. Lead plaintiff deadlines are set for September 21 or September 28, 2026.

stock
Park Ha is the defendant in the securities class actions, accused of failing to disclose a fraudulent stock promotion scheme. The company's stock collapsed 93% and it faces potential liability and reputational harm.
Importance 100.0 Sentiment -90.0
priv
Bronstein, Gewirtz & Grossman is one of the law firms that filed a class action against Park Ha, representing investors and seeking damages. The firm benefits from the litigation through potential fees.
Importance 70.0 Sentiment 20.0
priv
Rosen Law Firm announced a class action lawsuit against Park Ha and reminds investors of the lead plaintiff deadline. The firm is actively recruiting plaintiffs and may benefit from the case.
Importance 60.0 Sentiment 20.0
priv
Pomerantz LLP filed a class action lawsuit against Park Ha, alleging securities fraud and market manipulation. The firm represents investors and may gain from successful recovery.
Importance 60.0 Sentiment 20.0
priv
Levi & Korsinsky, through its SueWallSt brand, is involved in the class action against Park Ha, representing investors. The firm may gain from the litigation.
Importance 50.0 Sentiment 20.0
priv
Robbins LLP urged stockholders who lost money to contact the firm for information about their rights. It is participating in the class action.
Importance 40.0 Sentiment 20.0
cnt
The United States is the jurisdiction where the class actions are filed, and the securities laws are being enforced. The event may affect investor confidence in U.S. markets.
Importance 30.0 Sentiment -20.0
stock
L Oréal was mentioned in the alleged promotional scheme as a rumored partnership partner, but the deal had no basis. The company is not a defendant and is not directly affected.
Importance 30.0 Sentiment -10.0
per
Lawrence Rosen is a founding partner of Rosen Law Firm, which is involved in the class action. He is a prominent figure in the firm.
Importance 20.0 Sentiment 10.0
per
Philip Kim is an attorney at Rosen Law Firm, handling the class action and providing contact for investors. He is involved in the case.
Importance 20.0 Sentiment 10.0
per
Peretz Bronstein is a founding partner of Bronstein, Gewirtz & Grossman, one of the law firms representing investors. He is involved in the case.
Importance 20.0 Sentiment 10.0
per
Joseph E. Levi is an attorney at Levi & Korsinsky and SueWallSt, representing investors in the class action. He is involved in the case.
Importance 20.0 Sentiment 10.0
per
Nathan Miller is a client relations manager at Bronstein, Gewirtz & Grossman, providing contact for investors. He is not a key figure.
Importance 10.0 Sentiment 10.0
per
Danielle Peyton is a contact at Pomerantz LLP for investors. She is not a key figure.
Importance 10.0 Sentiment 10.0
Bronstein, Gewirtz & Grossman, LLC co-counsel Rosen Law Firm Bronstein, Gewirtz & Grossman, LLC frequently collaborates with Rosen Law Firm as co-counsel on investor-rights class ac
Bronstein, Gewirtz & Grossman, LLC co-plaintiffs Pomerantz LLP Bronstein, Gewirtz & Grossman, LLC frequently collaborates with Pomerantz LLP as co-plaintiffs in numerous class action
Bronstein, Gewirtz & Grossman, LLC co-counsel Robbins LLP Bronstein, Gewirtz & Grossman, LLC frequently serves as co-counsel with Robbins LLP in numerous securities class action
Rosen Law Firm co-plaintiff Pomerantz LLP Rosen Law Firm frequently acts as a co-plaintiff with Pomerantz LLP in numerous investor-rights class action lawsuits ag
Rosen Law Firm competitor Robbins LLP Rosen Law Firm frequently competes with Robbins LLP for lead plaintiff appointments in investor rights class action laws
Pomerantz LLP co-plaintiffs Robbins LLP Pomerantz LLP frequently acts as co-plaintiff with Robbins LLP in various investor-rights class action lawsuits against
+ 13 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.